Abstract:
The invention relates to aluminophosphate-based glasses suitable for use as a solid laser medium, which further contains SiO2 and B2O3. The laser glasses possess desirable figure of merit values for FOMTM and FOMlaser, as described herein.
Abstract translation:本发明涉及适合用作固体激光介质的磷酸铝基玻璃,其还含有SiO 2和B 2 O 3。 如本文所述,激光眼镜具有FOMTM和FOMlaser的所需品质因数值。
Abstract:
The present invention relates to fabrics, composites, prepregs, laminates, and other products incorporating glass fibers formed from glass compositions. The glass fibers, in some embodiments, are incorporated into composites that can be adapted for use in high energy impact applications such as ballistic or blast resistance applications. Glass fibers formed from some embodiments of the glass compositions can have certain desirable properties that can include, for example, desirable electrical properties (e.g. low Dk) or desirable mechanical properties (e.g., specific strength).
Abstract:
Glass compositions are provided that are useful in a variety of applications including, for example, electronics applications, reinforcement applications, and others. Some embodiments of glass compositions can provide desirable dielectric constants, desirable dissipation factors, and/or desirable mechanical properties while also having desirable fiber forming properties.
Abstract:
The present invention relates to materials comprising organic-inorganic polymeric networks. In some embodiments, the present invention provides an organic-inorganic composite material comprising an inorganic metal oxide matrix interpenetrating with a polymeric phase. Additionally, the present invention provides methods of producing organic-inorganic composite materials.
Abstract:
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B.
Abstract:
Methods and systems herein provide for calibrating for a plurality of different paper types. In one embodiment, a system for calibrating a printer includes a measurement module operable to detect colors printed on a first tangible medium by the printer and convert the detected colors to a detected color characterization. The system also includes a storage module operable to store a calibration file. The calibration file includes color characterizations of a plurality of different tangible mediums and each color characterization includes color measurements for one of the plurality of different tangible mediums obtained from the printer via the measurement module when the printer is calibrated. The system also includes a calibration module operable to compare the detected color characterization to at least two color characterizations of the calibration file and determine an adjustment to an output color scheme of the printer based on the comparison to calibrate the printer.
Abstract:
Embodiments of the present invention provides fiberizable glass compositions formed from batch compositions comprising significant amounts of one or more glassy minerals, including perlite and/or pumice.
Abstract:
Methods for inhibiting angiogenesis comprising administering tissue-plasminogen activator (tPA) inhibitors, and pharmaceutical compositions suitable for the methods comprising the tPA inhibitors. Also provided are methods for stimulating angiogenesis comprising administering tPA to a patient in need thereof, and pharmaceutical compositions comprising an effective amount of tPA for the methods of stimulation. The present invention discloses that tPA is a specific PDGF-C activating protease, and that the CUB-domains in PDGF-CC directly interact with the protease, are required for efficient proteolysis, and released CUB-domains are tPA inhibitors. Preferably, the method and compositions of the present invention are used for simultaneously stimulating, or simultaneously inhibiting, thrombolysis and angiogenesis.
Abstract:
A device and method of rendering visual information combine image information like video and secondary image information, like graphics. The image information and the secondary image information are processed for generating output information to be rendered in a three-dimensional space. The output information is arranged for display on a 3D stereoscopic display having a true display depth range (44). The processing includes detecting an image depth range of the image information, and detecting a secondary depth range of the secondary visual information. In the display depth range (44), a first sub-range (41) and second sub-range (43) are determined, which first sub-range and second sub-range are non-overlapping. The image depth range is accommodated in the first sub-range and the secondary depth range is accommodated in the second sub-range. Advantageously graphics and video are displayed in true 3D without video objects occluding graphical objects.
Abstract:
Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: In the compounds of Formula I, B or R2 is a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalkyl substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalkyl substituent connected directly to the ring or attached to the ring through a —CH2—.